Efficacy and safety of dostarlimab plus chemotherapy in patients with endometrial cancer by age category in part 1 of the ruby trial

Gold M., Bolling M. F., Sharma S., Kommoss S., Gilbert L., Ring K., ...Daha Fazla

INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, sa.SUPPL_3, 2024 (SCI-Expanded, Scopus)